First human test of new drug for asthma, COPD, and skin condition
NCT ID NCT05803902
Summary
This was an early-stage study to check the safety of a new injection called 9MW1911 in healthy people. The main goal was to see how well the body tolerated the drug and to find the highest safe dose. Researchers also measured how long the drug stayed in the body and if it triggered an immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.